{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T02:43:16Z","timestamp":1761964996775,"version":"3.37.3"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2018,8,3]],"date-time":"2018-08-03T00:00:00Z","timestamp":1533254400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81102065","81572667","81772902","81502114"],"award-info":[{"award-number":["81102065","81572667","81772902","81502114"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004735","name":"Natural Science Foundation of Hunan Province","doi-asserted-by":"publisher","award":["2018JJ1040"],"award-info":[{"award-number":["2018JJ1040"]}],"id":[{"id":"10.13039\/501100004735","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1007\/s11033-018-4288-3","type":"journal-article","created":{"date-parts":[[2018,8,3]],"date-time":"2018-08-03T00:52:04Z","timestamp":1533257524000},"page":"1277-1287","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Dual-functionality of RASSF1A overexpression in A375 cells is mediated by activation of IL-6\/STAT3 regulatory loop"],"prefix":"10.1007","volume":"45","author":[{"given":"Mei","family":"Yi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shengnan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ya","family":"Peng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junjun","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Cai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qian","family":"Peng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuanyuan","family":"Ban","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhaoyang","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoling","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guiyuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2641-5434","authenticated-orcid":false,"given":"Bo","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,8,3]]},"reference":[{"key":"4288_CR1","doi-asserted-by":"publisher","first-page":"1677","DOI":"10.4161\/cc.29082","volume":"13","author":"X Lou","year":"2014","unstructured":"Lou X, Zhang J, Liu S, Xu N, Liao DJ (2014) The other side of the coin: the tumor-suppressive aspect of oncogenes and the oncogenic aspect of tumor-suppressive genes, such as those along the CCND-CDK4\/6-RB axis. Cell Cycle 13:1677\u20131693. \n                    https:\/\/doi.org\/10.4161\/cc.29082","journal-title":"Cell Cycle"},{"key":"4288_CR2","first-page":"1639","volume":"63","author":"M Spugnardi","year":"2003","unstructured":"Spugnardi M, Tommasi S, Dammann R, Pfeifer GP, Hoon DS (2003) Epigenetic inactivation of RAS association domain family protein 1 (RASSF1A) in malignant cutaneous melanoma. Cancer Res 63:1639\u20131643","journal-title":"Cancer Res"},{"key":"4288_CR3","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1111\/j.1755-148X.2008.00484.x","volume":"21","author":"S Liu","year":"2008","unstructured":"Liu S, Ren S, Howell P, Fodstad O, Riker AI (2008) Identification of novel epigenetically modified genes in human melanoma via promoter methylation gene profiling. Pigm Cell Melanoma Res 21:545\u2013558. \n                    https:\/\/doi.org\/10.1111\/j.1755-148X.2008.00484.x","journal-title":"Pigm Cell Melanoma Res"},{"key":"4288_CR4","doi-asserted-by":"publisher","first-page":"231","DOI":"10.2174\/138920209788488526","volume":"10","author":"J Rother","year":"2009","unstructured":"Rother J, Jones D (2009) Molecular markers of tumor progression in melanoma. Curr Genom 10:231\u2013239. \n                    https:\/\/doi.org\/10.2174\/138920209788488526","journal-title":"Curr Genom"},{"key":"4288_CR5","doi-asserted-by":"publisher","first-page":"2360","DOI":"10.1002\/jcp.22568","volume":"226","author":"M Yi","year":"2011","unstructured":"Yi M, Yang J, Chen X, Li J, Li X, Wang L, Tan Y, Xiong W, Zhou M, McCarthy JB, Li G, Xiang B, Xie H (2011) RASSF1A suppresses melanoma development by modulating apoptosis and cell-cycle progression. J Cell Physiol 226:2360\u20132369. \n                    https:\/\/doi.org\/10.1002\/jcp.22568","journal-title":"J Cell Physiol"},{"key":"4288_CR6","doi-asserted-by":"publisher","first-page":"5002","DOI":"10.1002\/jcp.26349","volume":"233","author":"S Chen","year":"2018","unstructured":"Chen S, Zheng P, Wang W, Yi M, Chen P, Cai J, Li J, Peng Q, Ban Y, Zhou Y, Zeng Z, Li X, Xiong W, Li G, Xiang B (2018) Abberent expression of NOR1 protein in tumor associated macrophages contributes to the development of DEN-induced hepatocellular carcinoma. J Cell Physiol 233:5002\u20135013. \n                    https:\/\/doi.org\/10.1002\/jcp.26349","journal-title":"J Cell Physiol"},{"key":"4288_CR7","doi-asserted-by":"publisher","first-page":"2829","DOI":"10.1002\/jcp.25706","volume":"232","author":"W Wang","year":"2017","unstructured":"Wang W, Yi M, Chen S, Li J, Zhang H, Xiong W, Li G, Li X, Xiang B (2017) NOR1 suppresses cancer stem-like cells properties of tumor cells via the inhibition of the AKT-GSK-3beta-Wnt\/beta-catenin-ALDH1A1 signal circuit. J Cell Physiol 232:2829\u20132840. \n                    https:\/\/doi.org\/10.1002\/jcp.25706","journal-title":"J Cell Physiol"},{"key":"4288_CR8","doi-asserted-by":"publisher","first-page":"29919","DOI":"10.1074\/jbc.M611539200","volume":"282","author":"MB Nilsson","year":"2007","unstructured":"Nilsson MB, Armaiz-Pena G, Takahashi R, Lin YG, Trevino J, Li Y, Jennings N, Arevalo J, Lutgendorf SK, Gallick GE, Sanguino AM, Lopez-Berestein G, Cole SW, Sood AK (2007) Stress hormones regulate interleukin-6 expression by human ovarian carcinoma cells through a Src-dependent mechanism. J Biol Chem 282:29919\u201329926. \n                    https:\/\/doi.org\/10.1074\/jbc.M611539200","journal-title":"J Biol Chem"},{"key":"4288_CR9","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/s11010-017-3112-z","volume":"438","author":"W Wang","year":"2018","unstructured":"Wang W, Yi M, Zhang R, Li J, Chen S, Cai J, Zeng Z, Li X, Xiong W, Wang L, Li G, Xiang B (2018) Vimentin is a crucial target for anti-metastasis therapy of nasopharyngeal carcinoma. Mol Cell Biochem 438:47\u201357. \n                    https:\/\/doi.org\/10.1007\/s11010-017-3112-z","journal-title":"Mol Cell Biochem"},{"key":"4288_CR10","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.canlet.2014.03.005","volume":"348","author":"W Wang","year":"2014","unstructured":"Wang W, Li X, Zhang W, Li W, Yi M, Yang J, Zeng Z, Colvin Wanshura LE, McCarthy JB, Fan S, Zheng P, Chen S, Xiang B, Li G (2014) Oxidored-nitro domain containing protein 1 (NOR1) expression suppresses slug\/vimentin but not snail in nasopharyngeal carcinoma: inhibition of EMT in vitro and in vivo in mice. Cancer Lett 348:109\u2013118. \n                    https:\/\/doi.org\/10.1016\/j.canlet.2014.03.005","journal-title":"Cancer Lett"},{"key":"4288_CR11","doi-asserted-by":"publisher","first-page":"3742","DOI":"10.1038\/sj.onc.1202708","volume":"18","author":"M Kortylewski","year":"1999","unstructured":"Kortylewski M, Heinrich PC, Mackiewicz A, Schniertshauer U, Klingmuller U, Nakajima K, Hirano T, Horn F, Behrmann I (1999) Interleukin-6 and oncostatin M-induced growth inhibition of human A375 melanoma cells is STAT-dependent and involves upregulation of the cyclin-dependent kinase inhibitor p27\/Kip1. Oncogene 18:3742\u20133753. \n                    https:\/\/doi.org\/10.1038\/sj.onc.1202708","journal-title":"Oncogene"},{"key":"4288_CR12","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1097\/CMR.0000000000000021","volume":"23","author":"YR Na","year":"2013","unstructured":"Na YR, Lee JS, Lee SJ, Seok SH (2013) Interleukin-6-induced twist and N-cadherin enhance melanoma cell metastasis. Melanoma Res 23:434\u2013443. \n                    https:\/\/doi.org\/10.1097\/CMR.0000000000000021","journal-title":"Melanoma Res"},{"key":"4288_CR13","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1158\/1078-0432.CCR-07-0524","volume":"14","author":"S Verstovsek","year":"2008","unstructured":"Verstovsek S, Manshouri T, Quintas-Cardama A, Harris D, Cortes J, Giles FJ, Kantarjian H, Priebe W, Estrov Z (2008) WP1066, a novel JAK2 inhibitor, suppresses proliferation and induces apoptosis in erythroid human cells carrying the JAK2 V617F mutation. Clin Cancer Res 14:788\u2013796. \n                    https:\/\/doi.org\/10.1158\/1078-0432.CCR-07-0524","journal-title":"Clin Cancer Res"},{"key":"4288_CR14","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1038\/bjc.2015.221","volume":"113","author":"AM Grawenda","year":"2015","unstructured":"Grawenda AM, O\u2019Neill E (2015) Clinical utility of RASSF1A methylation in human malignancies. Br J Cancer 113:372\u2013381. \n                    https:\/\/doi.org\/10.1038\/bjc.2015.221","journal-title":"Br J Cancer"},{"key":"4288_CR15","doi-asserted-by":"publisher","first-page":"2824","DOI":"10.1158\/0008-5472.CAN-15-3010","volume":"76","author":"X Zhang","year":"2016","unstructured":"Zhang X, Guo C, Wu X, Li AX, Liu L, Tsark W, Dammann R, Shen H, Vonderfecht SL, Pfeifer GP (2016) Analysis of liver tumor-prone mouse models of the hippo kinase scaffold proteins RASSF1A and SAV1. Cancer Res 76:2824\u20132835. \n                    https:\/\/doi.org\/10.1158\/0008-5472.CAN-15-3010","journal-title":"Cancer Res"},{"key":"4288_CR16","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1038\/onc.2010.440","volume":"30","author":"S Tommasi","year":"2011","unstructured":"Tommasi S, Besaratinia A, Wilczynski SP, Pfeifer GP (2011) Loss of Rassf1a enhances p53-mediated tumor predisposition and accelerates progression to aneuploidy. Oncogene 30:690\u2013700. \n                    https:\/\/doi.org\/10.1038\/onc.2010.440","journal-title":"Oncogene"},{"key":"4288_CR17","doi-asserted-by":"publisher","first-page":"5729","DOI":"10.1038\/onc.2010.316","volume":"29","author":"M El-Kalla","year":"2010","unstructured":"El-Kalla M, Onyskiw C, Baksh S (2010) Functional importance of RASSF1A microtubule localization and polymorphisms. Oncogene 29:5729\u20135740. \n                    https:\/\/doi.org\/10.1038\/onc.2010.316","journal-title":"Oncogene"},{"key":"4288_CR18","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1016\/j.cub.2009.05.064","volume":"19","author":"A Dallol","year":"2009","unstructured":"Dallol A, Hesson LB, Matallanas D, Cooper WN, O\u2019Neill E, Maher ER, Kolch W, Latif F (2009) RAN GTPase is a RASSF1A effector involved in controlling microtubule organization. Curr Biol 19:1227\u20131232. \n                    https:\/\/doi.org\/10.1016\/j.cub.2009.05.064","journal-title":"Curr Biol"},{"key":"4288_CR19","doi-asserted-by":"publisher","first-page":"4244","DOI":"10.1158\/0008-5472.CAN-04-0339","volume":"64","author":"MD Vos","year":"2004","unstructured":"Vos MD, Martinez A, Elam C, Dallol A, Taylor BJ, Latif F, Clark GJ (2004) A role for the RASSF1A tumor suppressor in the regulation of tubulin polymerization and genomic stability. Cancer Res 64:4244\u20134250. \n                    https:\/\/doi.org\/10.1158\/0008-5472.CAN-04-0339","journal-title":"Cancer Res"},{"key":"4288_CR20","doi-asserted-by":"publisher","first-page":"4112","DOI":"10.1158\/0008-5472.CAN-04-0267","volume":"64","author":"A Dallol","year":"2004","unstructured":"Dallol A, Agathanggelou A, Fenton SL, Ahmed-Choudhury J, Hesson L, Vos MD, Clark GJ, Downward J, Maher ER, Latif F (2004) RASSF1A interacts with microtubule-associated proteins and modulates microtubule dynamics. Cancer Res 64:4112\u20134116. \n                    https:\/\/doi.org\/10.1158\/0008-5472.CAN-04-0267","journal-title":"Cancer Res"},{"key":"4288_CR21","doi-asserted-by":"publisher","first-page":"3817","DOI":"10.1158\/0008-5472.CAN-11-3343","volume":"72","author":"L Weyden van der","year":"2012","unstructured":"van der Weyden L, Papaspyropoulos A, Poulogiannis G, Rust AG, Rashid M, Adams DJ, Arends MJ, O\u2019Neill E (2012) Loss of RASSF1A synergizes with deregulated RUNX2 signaling in tumorigenesis. Cancer Res 72:3817\u20133827. \n                    https:\/\/doi.org\/10.1158\/0008-5472.CAN-11-3343","journal-title":"Cancer Res"},{"key":"4288_CR22","doi-asserted-by":"publisher","first-page":"4309","DOI":"10.1128\/MCB.22.12.4309-4318.2002","volume":"22","author":"L Shivakumar","year":"2002","unstructured":"Shivakumar L, Minna J, Sakamaki T, Pestell R, White MA (2002) The RASSF1A tumor suppressor blocks cell cycle progression and inhibits cyclin D1 accumulation. Mol Cell Biol 22:4309\u20134318","journal-title":"Mol Cell Biol"},{"key":"4288_CR23","doi-asserted-by":"publisher","first-page":"3019","DOI":"10.1016\/j.cub.2015.09.072","volume":"25","author":"N Vlahov","year":"2015","unstructured":"Vlahov N, Scrace S, Soto MS, Grawenda AM, Bradley L, Pankova D, Papaspyropoulos A, Yee KS, Buffa F, Goding CR, Timpson P, Sibson N, O\u2019Neill E (2015) Alternate RASSF1 transcripts control SRC activity, E-cadherin contacts, and YAP-mediated invasion. Curr Biol 25:3019\u20133034. \n                    https:\/\/doi.org\/10.1016\/j.cub.2015.09.072","journal-title":"Curr Biol"},{"key":"4288_CR24","doi-asserted-by":"publisher","first-page":"1748","DOI":"10.1158\/0008-5472.CAN-08-1377","volume":"69","author":"S Thaler","year":"2009","unstructured":"Thaler S, Hahnel PS, Schad A, Dammann R, Schuler M (2009) RASSF1A mediates p21Cip1\/Waf1-dependent cell cycle arrest and senescence through modulation of the Raf-MEK-ERK pathway and inhibition of Akt. Cancer Res 69:1748\u20131757. \n                    https:\/\/doi.org\/10.1158\/0008-5472.CAN-08-1377","journal-title":"Cancer Res"},{"key":"4288_CR25","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.bbcan.2009.11.002","volume":"1805","author":"A Marusyk","year":"2010","unstructured":"Marusyk A, Polyak K (2010) Tumor heterogeneity: causes and consequences. Biochim Biophys Acta 1805:105\u2013117. \n                    https:\/\/doi.org\/10.1016\/j.bbcan.2009.11.002","journal-title":"Biochim Biophys Acta"},{"key":"4288_CR26","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1158\/0008-5472.CAN-15-1008","volume":"76","author":"F Dubois","year":"2016","unstructured":"Dubois F, Keller M, Calvayrac O, Soncin F, Hoa L, Hergovich A, Parrini MC, Mazieres J, Vaisse-Lesteven M, Camonis J, Levallet G, Zalcman G (2016) RASSF1A Suppresses the invasion and metastatic potential of human non-small cell lung cancer cells by inhibiting YAP activation through the GEF-H1\/RhoB pathway. Cancer Res 76:1627\u20131640. \n                    https:\/\/doi.org\/10.1158\/0008-5472.CAN-15-1008","journal-title":"Cancer Res"},{"key":"4288_CR27","doi-asserted-by":"publisher","first-page":"134","DOI":"10.4143\/crt.2013.45.2.134","volume":"45","author":"HY Jung","year":"2013","unstructured":"Jung HY, Jung JS, Whang YM, Kim YH (2013) RASSF1A suppresses cell migration through inactivation of HDAC6 and increase of acetylated alpha-tubulin. Cancer Res Treat 45:134\u2013144. \n                    https:\/\/doi.org\/10.4143\/crt.2013.45.2.134","journal-title":"Cancer Res Treat"},{"key":"4288_CR28","doi-asserted-by":"publisher","first-page":"5537","DOI":"10.1002\/jcp.26410","volume":"233","author":"M Yi","year":"2018","unstructured":"Yi M, Cai J, Li J, Chen S, Zeng Z, Peng Q, Ban Y, Zhou Y, Li X, Xiong W, Li G, Xiang B (2018) Rediscovery of NF-kappaB signaling in nasopharyngeal carcinoma: How genetic defects of NF-kappaB pathway interplay with EBV in driving oncogenesis? J Cell Physiol 233:5537\u20135549. \n                    https:\/\/doi.org\/10.1002\/jcp.26410","journal-title":"J Cell Physiol"},{"key":"4288_CR29","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1186\/s13046-018-0784-5","volume":"37","author":"M Yi","year":"2018","unstructured":"Yi M, Li J, Chen S, Cai J, Ban Y, Peng Q, Zhou Y, Zeng Z, Peng S, Li X, Xiong W, Li G, Xiang B (2018) Emerging role of lipid metabolism alterations in cancer stem cells. J Exp Clin Cancer Res 37:118. \n                    https:\/\/doi.org\/10.1186\/s13046-018-0784-5","journal-title":"J Exp Clin Cancer Res"},{"key":"4288_CR30","doi-asserted-by":"publisher","first-page":"626","DOI":"10.7150\/jca.17579","volume":"8","author":"M Yi","year":"2017","unstructured":"Yi M, Yang J, Li W, Li X, Xiong W, McCarthy JB, Li G, Xiang B (2017) The NOR1\/OSCP1 proteins in cancer: from epigenetic silencing to functional characterization of a novel tumor suppressor. J Cancer 8:626\u2013635. \n                    https:\/\/doi.org\/10.7150\/jca.17579","journal-title":"J Cancer"},{"key":"4288_CR31","doi-asserted-by":"publisher","first-page":"16745","DOI":"10.18632\/oncotarget.7778","volume":"7","author":"W Wang","year":"2016","unstructured":"Wang W, Yi M, Chen S, Li J, Li G, Yang J, Zheng P, Zhang H, Xiong W, McCarthy JB, Li G, Li X, Xiang B (2016) Significance of the NOR1-FOXA1\/HDAC2-Slug regulatory network in epithelial-mesenchymal transition of tumor cells. Oncotarget 7:16745\u201316759. \n                    https:\/\/doi.org\/10.18632\/oncotarget.7778","journal-title":"Oncotarget"},{"key":"4288_CR32","doi-asserted-by":"publisher","DOI":"10.1002\/jcp.26343","author":"H Lu","year":"2017","unstructured":"Lu H, Han M, Yuan X, Tursun K, Zhang Y, Li Y, Li Z, Feng S, Zhou L, Pan Z, Wang Q, Han K, Liu S, Cheng J (2017) Role of IL-6-mediated expression of NS5ATP9 in autophagy of liver cancer cells. J Cell Physiol. \n                    https:\/\/doi.org\/10.1002\/jcp.26343","journal-title":"J Cell Physiol"},{"key":"4288_CR33","doi-asserted-by":"publisher","first-page":"1862","DOI":"10.1002\/jcp.25724","volume":"232","author":"Y Nishikawa","year":"2017","unstructured":"Nishikawa Y, Kajiura Y, Lew JH, Kido JI, Nagata T, Naruishi K (2017) Calprotectin induces IL-6 and MCP-1 production via toll-like receptor 4 signaling in human gingival fibroblasts. J Cell Physiol 232:1862\u20131871. \n                    https:\/\/doi.org\/10.1002\/jcp.25724","journal-title":"J Cell Physiol"},{"key":"4288_CR34","first-page":"3537","volume":"35","author":"R Kucera","year":"2015","unstructured":"Kucera R, Topolcan O, Treskova I, Kinkorova J, Windrichova J, Fuchsova R, Svobodova S, Treska V, Babuska V, Novak J, Smejkal J (2015) Evaluation of IL-2, IL-6, IL-8 and IL-10 in malignant melanoma diagnostics. Anticancer Res 35:3537\u20133541","journal-title":"Anticancer Res"},{"key":"4288_CR35","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1385\/MO:22:3:241","volume":"22","author":"F Tas","year":"2005","unstructured":"Tas F, Oguz H, Argon A, Duranyildiz D, Camlica H, Yasasever V, Topuz E (2005) The value of serum levels of IL-6, TNF-alpha, and erythropoietin in metastatic malignant melanoma: serum IL-6 level is a valuable prognostic factor at least as serum LDH in advanced melanoma. Med Oncol 22:241\u2013246. \n                    https:\/\/doi.org\/10.1385\/MO:22:3:241","journal-title":"Med Oncol"},{"key":"4288_CR36","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.trecan.2016.11.008","volume":"3","author":"S Colak","year":"2017","unstructured":"Colak S, Ten Dijke P (2017) Targeting TGF-beta signaling in cancer. Trends Cancer 3:56\u201371. \n                    https:\/\/doi.org\/10.1016\/j.trecan.2016.11.008","journal-title":"Trends Cancer"},{"key":"4288_CR37","doi-asserted-by":"publisher","first-page":"2482","DOI":"10.1002\/jcp.25361","volume":"231","author":"S Majumder","year":"2016","unstructured":"Majumder S, Bhowal A, Basu S, Mukherjee P, Chatterji U, Sengupta S (2016) Deregulated E2F5\/p38\/SMAD3 circuitry reinforces the pro-tumorigenic switch of TGFbeta signaling in prostate cancer. J Cell Physiol 231:2482\u20132492. \n                    https:\/\/doi.org\/10.1002\/jcp.25361","journal-title":"J Cell Physiol"},{"key":"4288_CR38","doi-asserted-by":"publisher","first-page":"1801","DOI":"10.1158\/1078-0432.CCR-08-1361","volume":"15","author":"A Tanemura","year":"2009","unstructured":"Tanemura A, Terando AM, Sim MS, van Hoesel AQ, de Maat MF, Morton DL, Hoon DS (2009) CpG island methylator phenotype predicts progression of malignant melanoma. Clin Cancer Res 15:1801\u20131807. \n                    https:\/\/doi.org\/10.1158\/1078-0432.CCR-08-1361","journal-title":"Clin Cancer Res"},{"key":"4288_CR39","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.14670\/HH-22.1005","volume":"22","author":"M Rastetter","year":"2007","unstructured":"Rastetter M, Schagdarsurengin U, Lahtz C, Fiedler E, Marsch W, Dammann R, Helmbold P (2007) Frequent intra-tumoural heterogeneity of promoter hypermethylation in malignant melanoma. Histol Histopathol 22:1005\u20131015. \n                    https:\/\/doi.org\/10.14670\/HH-22.1005","journal-title":"Histol Histopathol"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11033-018-4288-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-018-4288-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-018-4288-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,25]],"date-time":"2019-09-25T11:41:07Z","timestamp":1569411667000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11033-018-4288-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,3]]},"references-count":39,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018,10]]}},"alternative-id":["4288"],"URL":"https:\/\/doi.org\/10.1007\/s11033-018-4288-3","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"type":"print","value":"0301-4851"},{"type":"electronic","value":"1573-4978"}],"subject":[],"published":{"date-parts":[[2018,8,3]]},"assertion":[{"value":"25 May 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 July 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 August 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}